Beximco Pharmaceuticals Limited (AIM: BXP)
21.50
0.00 (0.00%)
Sep 11, 2024, 4:14 PM GMT+1
Beximco Pharmaceuticals Revenue
Beximco Pharmaceuticals had revenue of 10.99B BDT in the quarter ending March 31, 2024, with 15.00% growth. This brings the company's revenue in the last twelve months to 43.08B, up 13.46% year-over-year. In the fiscal year ending June 30, 2023, Beximco Pharmaceuticals had annual revenue of 39.27B with 13.26% growth.
Revenue (ttm)
43.08B BDT
Revenue Growth
+13.46%
P/S Ratio
0.31
Revenue / Employee
7.56M BDT
Employees
5,700
Market Cap
215.61M GBP
Revenue Chart
* This company reports financials in BDT.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Jun 30, 2023 | 39.27B | 4.60B | 13.26% |
Jun 30, 2022 | 34.67B | 5.18B | 17.55% |
Jun 30, 2021 | 29.49B | 3.88B | 15.16% |
Jun 30, 2020 | 25.61B | 2.80B | 12.25% |
Jun 30, 2019 | 22.82B | 5.10B | 28.79% |
Jun 30, 2018 | Pro | Pro | Pro |
Jun 30, 2017 | Pro | Pro | Pro |
Jun 30, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Dec 31, 2014 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionBeximco Pharmaceuticals News
- 8 days ago - Small Cap Stocks: Indus Gas, VAST Resources, Beximco - The Armchair Trader